Advertisement Positron and Disease Management to co-develop heart disease management solution - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Positron and Disease Management to co-develop heart disease management solution

Positron and Disease Management have announced an agreement to co-develop a coronary artery disease prevention and reversal software program and total disease management solution.

The product will include a heart disease pre-test risk calculator, a coronary disease reversal and prevention practice management program, a web-based, patient centric, disease reversal and life style modification program, an interpreting and referring physician portal, as well as a cost efficacy and patient outcomes tracker.

Joseph Oliverio, Positron’s president, said: “The development of our heart disease management solution will help us reach beyond our current molecular imaging targeted business to offer a product to payers, self insured corporations, multi-specialty groups, cardiology groups, hospitals and finally direct to the consumer.”